Se Hwan Yang

541 total citations
28 papers, 423 citations indexed

About

Se Hwan Yang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Se Hwan Yang has authored 28 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Se Hwan Yang's work include Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (9 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Se Hwan Yang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (9 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Se Hwan Yang collaborates with scholars based in South Korea, United States and Australia. Se Hwan Yang's co-authors include Young Chul Sung, You Suk Suh, Se Jin Im, Seung Kew Yoon, Si Hyun Bae, Chang Wook Kim, Jeong Won Jang, Wonhee Hur, Sung Key Jang and Yong Bok Seo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Se Hwan Yang

27 papers receiving 407 citations

Peers

Se Hwan Yang

IMMUN

EPIDE

HEPAT

ONCOL

Fanching Lin United States

Daniel Byrd United States

Yuki Nishimura‐Sakurai Japan

Ewa Terczyńska‐Dyla Denmark

Mayumi Ueyama Japan

Alex Sette United States

Noha G. Bader El Din Egypt

E. Yamada Japan

Hideyuki Kato Japan

P. H. Hofschneider Germany

Fanching Lin United States

Se Hwan Yang

210 ×1.2

IMMUN

80 ×0.6

EPIDE

97 ×0.9

58 ×0.5

HEPAT

83 ×1.2

ONCOL

Citations per year, relative to Se Hwan Yang Se Hwan Yang (= 1×) peers Fanching Lin

Countries citing papers authored by Se Hwan Yang

Since Specialization

Citations

This map shows the geographic impact of Se Hwan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Se Hwan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Se Hwan Yang more than expected).

Fields of papers citing papers by Se Hwan Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Se Hwan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Se Hwan Yang. The network helps show where Se Hwan Yang may publish in the future.

Co-authorship network of co-authors of Se Hwan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Se Hwan Yang. A scholar is included among the top collaborators of Se Hwan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Se Hwan Yang. Se Hwan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Gun Min, So Jeong Kim, Myung Ah Lee, et al.. (2025). GX-I7, a long-acting IL-7, safely and effectively increased peripheral CD8+/CD4+ T cells and TILs in patients with locally advanced or metastatic solid tumours. British Journal of Cancer. 133(4). 524–532. 2 indexed citations

Kim, Richard D., Hirva Mamdani, Minal Barve, et al.. (2024). A phase 2a study of NT-I7 (efineptakin alfa), a long-acting IL-7, and pembrolizumab to evaluate efficacy, including overall survival, in hard-to-treat gastrointestinal tumors.. Journal of Clinical Oncology. 42(16_suppl). 2621–2621. 1 indexed citations

Choi, Donghoon, et al.. (2024). Enabling immune checkpoint blockade efficacy in T-lymphopenia by restoring CD8 T cell dynamics with IL-7 cytokine therapy. Frontiers in Immunology. 15. 1477171–1477171. 1 indexed citations

Naing, Aung, Hirva Mamdani, Minal Barve, et al.. (2023). 652 NT-I7 (efineptakin alfa), a long-acting IL-7, in combination with pembrolizumab improves T cell fitness in heavily pretreated subjects with gastrointestinal tumors. SHILAP Revista de lepidopterología. A743–A743. 1 indexed citations

Yang, Se Hwan, et al.. (2022). Recent progress on the seasonal tropical cyclone predictions over the western North Pacific from 2014 to 2020. SHILAP Revista de lepidopterología. 11(1). 26–35. 5 indexed citations

Naing, Aung, Michael Ware, Cara Haymaker, et al.. (2022). 657 NT-I7, a long-acting IL-7, plus pembrolizumab favors CD8 T-cell infiltration in liver metastases of heavily pre-treated, immunologically cold, MSS-colorectal and pancreatic cancer. Regular and Young Investigator Award Abstracts. A688–A688. 2 indexed citations

Kim, Sojeong, June‐Young Koh, Donghoon Choi, et al.. (2022). A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions. Blood Advances. 6(23). 6093–6107. 11 indexed citations

Campian, Jian, Jingqin Luo, Albert H. Kim, et al.. (2021). A phase I/II study to evaluate the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy: The interim result of the phase I data.. Journal of Clinical Oncology. 39(15_suppl). 2040–2040. 4 indexed citations

Ghosh, Subhajit, Ran Yan, Arijita Jash, et al.. (2020). 565 A novel long-acting interleukin-7 agonist, NT-I7, increases cytotoxic CD8+ T cells and enhances survival in mouse glioma models. SHILAP Revista de lepidopterología. A340.2–A340. 2 indexed citations

10.

Choi, Donghoon, Eui‐Cheol Shin, Su‐Hyung Park, et al.. (2020). hIL‐7‐hyFc, A Long‐Acting IL‐7, Increased Absolute Lymphocyte Count in Healthy Subjects. Clinical and Translational Science. 13(6). 1161–1169. 30 indexed citations

11.

Yoon, Seung Kew, Yong Bok Seo, Se Jin Im, et al.. (2014). Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice. Liver International. 35(3). 805–815. 50 indexed citations

12.

Yang, Se Hwan, et al.. (2012). A long-acting erythropoietin fused with noncytolytic human Fc for the treatment of anemia. Archives of Pharmacal Research. 35(5). 757–759. 11 indexed citations

13.

Lee, Jung Hwan, Sung Hee Lee, Se Hwan Yang, et al.. (2012). Biochemical characterization of a new recombinant TNF receptor-hyFc fusion protein expressed in CHO cells. Protein Expression and Purification. 87(1). 17–26. 7 indexed citations

14.

Lee, Jung‐Hwan, Jong Ho Cho, Sung Hee Lee, et al.. (2012). The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein. Biologicals. 41(2). 77–83. 13 indexed citations

15.

Choi, Dong Hoon, Kwang Soon Kim, Se Hwan Yang, et al.. (2011). Dendritic Cell Internalization of α-Galactosylceramide from CD8 T Cells Induces Potent Antitumor CD8 T-cell Responses. Cancer Research. 71(24). 7442–7451. 8 indexed citations

16.

Im, Se Jin, Se Hwan Yang, Dong Hoon Choi, et al.. (2011). Natural Form of Noncytolytic Flexible Human Fc as a Long-Acting Carrier of Agonistic Ligand, Erythropoietin. PLoS ONE. 6(9). e24574–e24574. 23 indexed citations

17.

Kim, Chae Young, Seon Beom Kim, Se Jin Im, et al.. (2008). Increased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporation. Experimental & Molecular Medicine. 40(6). 669–669. 29 indexed citations

18.

Kim, Chae Young, et al.. (2007). In vivo kinetics and biodistribution of HB-110, a novel HBV DNA vaccine, after administration in Mice. Archives of Pharmacal Research. 30(3). 355–360. 6 indexed citations

19.

Hur, Wonhee, Jeong Won Jang, Chang Wook Kim, et al.. (2005). HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-β1. Experimental & Molecular Medicine. 37(2). 138–145. 94 indexed citations

20.

Suh, You Suk, et al.. (1997). Comparison of Various Expression Plasmids for the Induction of Immune Response by DNA Immunization. Molecules and Cells. 7(4). 495–501. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact